Abstract:With the development of high-throughput technology and the accumulation of biomedical data, the prior information of biological entity can be calculated from different aspects. Specifically, drug-drug similarities can be measured from target profiles, drug-drug interaction and side effects. Similarly, different methods and data sources to calculate disease ontology can result in multiple measures of pairwise disease similarities. Therefore, in computational drug repositioning, developing a dynamic method to optimize the fusion process of multiple similarities is a crucial and challenging task. In this study, we propose a multi-similarities bilinear matrix factorization (MSBMF) method to predict promising drug-associated indications for existing and novel drugs. Instead of fusing multiple similarities into a single similarity matrix, we concatenate these similarity matrices of drug and disease, respectively. Applying matrix factorization methods, we decompose the drug-disease association matrix into a drug-feature matrix and a disease-feature matrix. At the same time, using these feature matrices as basis, we extract effective latent features representing the drug and disease similarity matrices to infer missing drug-disease associations. Moreover, these two factored matrices are constrained by non-negative factorization to ensure that the completed drug-disease association matrix is biologically interpretable. In addition, we numerically solve the MSBMF model by an efficient alternating direction method of multipliers algorithm. The computational experiment results show that MSBMF obtains higher prediction accuracy than the state-of-the-art drug repositioning methods in cross-validation experiments. Case studies also demonstrate the effectiveness of our proposed method in practical applications. Availability: The data and code of MSBMF are freely available at https://github.com/BioinformaticsCSU/MSBMF. Corresponding author: Jianxin Wang, School of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, P. R. China. E-mail: jxwang@mail.csu.edu.cn Supplementary Data: Supplementary data are available online at https://academic.oup.com/bib.

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Link Prediction Only with Interaction Data and Its Application on Drug Repositioning

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

Predicting drug-disease associations by network embedding and biomedical data integration.

DDAPRED: a Computational Method for Predicting Drug Repositioning Using Regularized Logistic Matrix Factorization

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Similarity-Based Integrated Method For Predicting Drug-Disease Interactions

Drug-Protein-Disease Association Prediction and Drug Repositioning Based on Tensor Decomposition.

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks